These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 4428468

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intravenous versus intraperitoneal administration of dextran in the rabbit: effects on fibrinolysis.
    Wagaman R, Ingram JM, Rao PS, Saba HI.
    Am J Obstet Gynecol; 1986 Sep; 155(3):464-70. PubMed ID: 2428247
    [Abstract] [Full Text] [Related]

  • 24. Effects of collagen on fibrinolysis.
    Engel AM, Alexander B.
    Thromb Diath Haemorrh Suppl; 1973 Sep; 56():63-74. PubMed ID: 4376277
    [No Abstract] [Full Text] [Related]

  • 25. Dextran sulfate-dependent fibrinolysis in whole human plasma.
    Miles LA, Rothschild Z, Griffin JH.
    J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
    [Abstract] [Full Text] [Related]

  • 26. Induction of fibrinolysis by polyanions in human plasma.
    Klauser RJ.
    Thromb Haemost; 1988 Oct 31; 60(2):324-7. PubMed ID: 2464201
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW.
    Agents Actions Suppl; 1992 Oct 31; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [Abstract] [Full Text] [Related]

  • 29. THE ASSESSMENT OF FIBRINOLYTIC ACTIVITY IN THE BLOOD.
    FLUTE PT.
    Br Med Bull; 1964 Sep 31; 20():195-9. PubMed ID: 14209758
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. HAGEMAN FACTOR AND IN VIVO ACTIVATION OF FIBRINOLYSIS.
    HOLEMANS R, ROBERTS HR.
    J Lab Clin Med; 1964 Nov 31; 64():778-86. PubMed ID: 14226397
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Postmortem fibrinolysis and its biological characteristics].
    Bratchik AM.
    Probl Gematol Pereliv Krovi; 1975 Jun 31; 20(6):18-22. PubMed ID: 124429
    [Abstract] [Full Text] [Related]

  • 35. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP, Ferguson JH.
    Thromb Diath Haemorrh; 1970 Oct 31; 24(1):1-9. PubMed ID: 4249468
    [No Abstract] [Full Text] [Related]

  • 36. [Factor XII (HAGEMAN FACTOR)].
    Kase F, Klír P, Pospísil J, Poucková P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978 Oct 31; 105(1):1-19. PubMed ID: 77809
    [Abstract] [Full Text] [Related]

  • 37. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
    Tsuda H, Miyata T, Iwanaga S, Yamamoto T.
    Thromb Haemost; 1992 Apr 02; 67(4):440-4. PubMed ID: 1631792
    [Abstract] [Full Text] [Related]

  • 38. Plasma inhibitors of the Hageman factor dependent pathways.
    Schreiber AD.
    Semin Thromb Hemost; 1976 Jul 02; 3(1):32-51. PubMed ID: 799348
    [Abstract] [Full Text] [Related]

  • 39. Sustained fibrinolytic activity in the euglobulin fraction induced by concomitant administration of urokinase and dextran sulphate.
    Matsuo O, Kawaguchi T, Kosugi T, Mihara H.
    Thromb Res; 1978 Dec 02; 13(6):1125-30. PubMed ID: 749265
    [No Abstract] [Full Text] [Related]

  • 40. Fibrinolytic properties of activated FXII.
    Braat EA, Dooijewaard G, Rijken DC.
    Eur J Biochem; 1999 Aug 02; 263(3):904-11. PubMed ID: 10469157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.